These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 21651447)
1. The effect of pitavastatin calcium on endothelial dysfunction induced by hypercholesterolemia. Yan HM; Zhao J; Ma DZ; Wang H; Wang J; Wang ZH; Li L; Zhang Y; Zhang W; Zhong M Expert Opin Pharmacother; 2011 Jul; 12(10):1463-71. PubMed ID: 21651447 [TBL] [Abstract][Full Text] [Related]
2. Pitavastatin calcium improves endothelial function and delays the progress of atherosclerosis in patients with hypercholesterolemia. Zhao J; Yan HM; Li Y; Wang J; Han L; Wang ZH; Tang MX; Zhang W; Zhang Y; Zhong M J Zhejiang Univ Sci B; 2015 May; 16(5):380-7. PubMed ID: 25990055 [TBL] [Abstract][Full Text] [Related]
3. Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Yoshida O; Kondo T; Kureishi-Bando Y; Sugiura T; Maeda K; Okumura K; Murohara T Circ J; 2010 Jan; 74(1):195-202. PubMed ID: 19926918 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin and pravastatin equally improve flow-mediated dilation in males with hypercholesterolemia. Sebestjen M; Boh M; Keber I Wien Klin Wochenschr; 2002 Dec; 114(23-24):999-1003. PubMed ID: 12635468 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
6. Pitavastatin: an overview. Saito Y Atheroscler Suppl; 2011 Nov; 12(3):271-6. PubMed ID: 22152281 [TBL] [Abstract][Full Text] [Related]
7. Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial. Balletshofer BM; Goebbel S; Rittig K; Enderle M; Schmölzer I; Wascher TC; Ferenc Pap A; Westermeier T; Petzinna D; Matthaei S; Häring HU Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):324-30. PubMed ID: 15977099 [TBL] [Abstract][Full Text] [Related]
8. Effect of pitavastatin on vascular reactivity in hypercholesterolemic rabbits. Almeida EA; Ozaki MR Arq Bras Cardiol; 2014 Jul; 103(1):4-12. PubMed ID: 25014056 [TBL] [Abstract][Full Text] [Related]
9. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients. Egede R; Jensen LO; Hansen HS; Antonsen L; Hansen KN; Junker A; Thayssen P Int J Cardiol; 2012 Jul; 158(3):376-9. PubMed ID: 21349594 [TBL] [Abstract][Full Text] [Related]
10. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
11. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637 [TBL] [Abstract][Full Text] [Related]
12. Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients. Hamilton SJ; Chew GT; Davis TM; Watts GF Clin Sci (Lond); 2010 Feb; 118(10):607-15. PubMed ID: 20047560 [TBL] [Abstract][Full Text] [Related]
13. Comparison of pitavastatin with atorvastatin in increasing HDL-cholesterol and adiponectin in patients with dyslipidemia and coronary artery disease: the COMPACT-CAD study. Kurogi K; Sugiyama S; Sakamoto K; Tayama S; Nakamura S; Biwa T; Matsui K; Ogawa H; J Cardiol; 2013 Aug; 62(2):87-94. PubMed ID: 23672789 [TBL] [Abstract][Full Text] [Related]
15. Improvement of endothelial function by pitavastatin: a meta-analysis. Katsiki N; Reiner Ž; Tedeschi Reiner E; Al-Rasadi K; Pirro M; Mikhailidis DP; Sahebkar A Expert Opin Pharmacother; 2018 Feb; 19(3):279-286. PubMed ID: 29334477 [TBL] [Abstract][Full Text] [Related]
16. Fluvastatin reduces oxidative stress, decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia. Leu HB; Wu CC; Wu TC; Lin SJ; Chen JW J Formos Med Assoc; 2004 Dec; 103(12):914-20. PubMed ID: 15624040 [TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. Sansanayudh N; Wongwiwatthananukit S; Putwai P; Dhumma-Upakorn R Ann Pharmacother; 2010 Mar; 44(3):415-23. PubMed ID: 20179259 [TBL] [Abstract][Full Text] [Related]
18. Impact of pitavastatin on high-sensitivity C-reactive protein and adiponectin in hypercholesterolemic patients with the metabolic syndrome: the PREMIUM Study. Matsubara T; Naruse K; Arakawa T; Nakao M; Yokoi K; Oguri M; Marui N; Amano T; Ichimiya S; Ohashi T; Imai K; Sakai S; Sugiyama S; Ishii H; Murohara T J Cardiol; 2012 Nov; 60(5):389-94. PubMed ID: 22884685 [TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia. Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486 [TBL] [Abstract][Full Text] [Related]
20. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation. Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]